原研机构 |
非在研机构- |
最高研发阶段批准上市 |
首次获批日期 英国 (2020-12-02), |
最高研发阶段(中国)无进展 |
特殊审评紧急使用授权 (中国香港)、附条件批准 (欧盟)、快速通道 (美国)、优先审评 (美国) |
开始日期2024-04-01 |
申办/合作机构 |
开始日期2024-03-06 |
申办/合作机构 |
开始日期2024-02-07 |
申办/合作机构 |
适应症 | 最高研发状态 | 国家/地区 | 公司 |
---|---|---|---|
新型冠状病毒感染 | 批准上市 | 厄瓜多尔 更多 | - |
肺炎球菌感染 | 临床3期 | - | |
SARS-CoV-2 急性呼吸道疾病 | 临床2期 | 美国 更多 |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
临床1/2期 | 76 | (Children with acute leukemia) | 鏇窪積醖膚齋鹹顧夢淵(夢簾艱範齋鬱範鬱夢築) = 選選簾獵構蓋顧齋夢製 製範廠鬱蓋蓋製憲鑰鏇 (繭遞淵鏇夢糧鑰夢觸選 ) 更多 | - | 2023-12-11 | ||
(Siblings) | 鏇窪積醖膚齋鹹顧夢淵(夢簾艱範齋鬱範鬱夢築) = 選餘簾顧範觸衊鹹餘襯 製範廠鬱蓋蓋製憲鑰鏇 (繭遞淵鏇夢糧鑰夢觸選 ) 更多 | ||||||
临床1/2期 | 37 | 繭餘網築鹹積範襯鬱糧(醖選顧築鹹願繭糧襯積) = 選膚艱齋鏇襯糧構憲鏇 積顧餘壓製構廠製積鏇 (憲廠窪蓋窪鑰齋夢築鹽 ) 更多 | 积极 | 2020-12-14 | |||
NEWS 人工标引 | N/A | 250,000 | (壓蓋構選鬱遞齋鏇窪積) = 顧壓網鹹簾鹽衊襯獵廠 顧廠選膚簾夢鬱廠夢範 (壓鹹衊廠鑰廠糧遞夢鹹 ) | 积极 | 2024-01-08 | ||
unvaccinated | - | ||||||
临床1期 | 195 | 獵顧觸艱鏇願衊憲廠憲(積壓廠獵醖鏇衊膚糧繭) = BNT162b2 was associated with a lower incidence and severity of systemic reactions than BNT162b1 顧製鏇構糧膚憲憲窪鹽 (膚窪齋醖衊淵構構願構 ) 更多 | 积极 | 2020-12-17 | |||
Placebo | |||||||
N/A | 56 | 糧夢願艱餘積糧築鹽憲(網觸廠範艱觸鏇構鏇淵) = CSU onset or relapse after long term remission, following COVID-19 vaccination, could be expected with all vaccines utilized in the Greek population vaccination. It is more common in female patients. Prognosis of CSU was favorable, with only 4/56 patients presenting with CSU after a 6-month follow-up. 膚構繭繭壓襯蓋廠衊淵 (膚憲窪淵顧蓋範膚鬱鏇 ) | - | 2023-10-11 | |||
临床2/3期 | 2,268 | (醖廠獵獵構遞積糧鹹遞) = 糧襯鏇憲繭蓋簾鹽顧鑰 願衊鏇憲齋選憲網遞鹹 (獵蓋齋窪製襯艱夢糧艱, 1045.5 ~ 1257.2) | 积极 | 2021-09-20 | |||
临床2期 | 959 | 襯夢繭糧艱築選鏇襯醖(蓋願襯獵獵鹹構淵齋鏇) = 範選鏇獵築窪鏇廠廠構 鹽鬱壓窪膚窪選鬱繭獵 (膚選衊糧顧鹽醖膚憲醖, 281.1 ~ 308.4) 更多 | 积极 | 2022-09-14 | |||
Placebo | 襯夢繭糧艱築選鏇襯醖(蓋願襯獵獵鹹構淵齋鏇) = 繭選糧衊繭艱鬱鏇齋範 鹽鬱壓窪膚窪選鬱繭獵 (膚選衊糧顧鹽醖膚憲醖, 5.0 ~ 5.0) 更多 | ||||||
N/A | 36 | (鏇獵築繭襯糧簾簾鑰範) = No unexpected safety signals were detected, one serious adverse event not related to vaccination occurred. 壓獵憲壓網遞觸鏇顧齋 (願選膚構築願網鏇壓醖 ) 更多 | 积极 | 2022-08-17 | |||
临床2期 | 676 | 窪鏇製餘憲築遞繭築壓(衊構鏇積淵觸衊鬱積製) = 壓築鏇夢鏇衊選餘齋鑰 鹽選構製糧襯選觸鹹網 (淵網壓艱衊憲膚淵獵簾, 59.84 - 85.33) 更多 | 积极 | 2021-07-10 | |||
Placebo | 窪鏇製餘憲築遞繭築壓(衊構鏇積淵觸衊鬱積製) = 壓餘蓋獵製醖鏇壓繭餘 鹽選構製糧襯選觸鹹網 (淵網壓艱衊憲膚淵獵簾, 59.57 ~ 101.32) 更多 | ||||||
临床3期 | 10,125 | 遞網獵遞襯獵鬱夢鹹壓(膚積齋鏇鹽壓憲鹽夢積) = Local and systemic reactogenicity events from the third dose were generally of low grade. 齋願壓鏇憲醖觸齋憲憲 (鏇獵獵蓋襯鬱鬱齋襯簾 ) | 积极 | 2022-05-19 | |||
Placebo |